Proxima
Reprograming protein-protein interactions to unlock new small-molecule therapies for cancer, autoimmune disorders, and other hard-to-treat diseases
The factors that make people vulnerable to chronic disease are partly social and economic — and can be modeled and predicted, with the right technology. Medical networks use Akido’s platform to track members’ medical histories and life events and intervene proactively. A patient who loses a job or becomes homeless, for example, can be flagged for screening or treatment to prevent downstream health complications such as hypertension or pre-diabetes.
Reprograming protein-protein interactions to unlock new small-molecule therapies for cancer, autoimmune disorders, and other hard-to-treat diseases
Transforming biology from a science into engineering
Using AI models trained on digital pathology images to help oncologists make smarter cancer treatment decisions
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing